A recent study presented that elevated plasma concentrations of syndecan-1 and hyaluronan in patients with end-stage chronic kidney disease decreased three months after kidney transplantation, suggesting the regression of endothelial dysfunction [52]. The gene discussed is SDC1; the disease is endothelial dysfunction.